| LAZARD EMERGING MARKETS EQUITY C ACC EUR | RVI EMERGENTES | 50,00% | 96,33% | 97,90% | · |
| BRANDES EUROPEAN VALUE FUND A USD CAP | RVI EUROPA VALOR | 23,17% | 75,38% | 97,86% | 161,50% |
| LAZARD EMERGING MARKETS EQUITY A ACC USD | RVI EMERGENTES | 47,53% | 95,69% | 97,83% | · |
| ERSTE STOCK ISTANBUL VTA HUF R01 | RVI EMERGENTES EUROPA | -0,04% | 6,63% | 97,79% | 22,30% |
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 EUR HEDGED | RVI BIOTECNOLOGÍA | 65,03% | 87,62% | 97,67% | · |
| SCHRODER ISF EUROPEAN VALUE C ACC EUR | RVI EUROPA VALOR | 29,81% | 61,94% | 97,64% | 152,35% |
| SABADELL ESPAÑA BOLSA FUTURO, FI PREMIER | RV ESPAÑA SMALL/MID CAP | 22,53% | 63,47% | 97,47% | 145,72% |
| BNY MELLON GLOBAL INFRASTRUCTURE INCOME FUND USD W (ACC) | RVI INFRAESTRUCTURA | 19,30% | 75,33% | 97,42% | · |
| AMUNDI MSCI JAPAN SRI CLIMATE PARIS ALIGNED UCITS ETF DR USD HEDGED CAP | RVI JAPÓN | 28,29% | 55,02% | 97,41% | · |
| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 60,03% | 97,09% | 97,40% | 333,47% |
